|
Robert Kennedy, PhD, is Chief Scientific Officer of Vestaron Corporation. With over 25 years of research management experience, Dr. Kennedy leads Vestaron’s molecular biology and chemistry development teams. Management positions in Fortune 500 companies (Pfizer), academic appointments (Columbia University, University of Michigan) and start-ups add to the leadership and technical experience he brings to Vestaron’s Research and Development success.